Vaccines, Attenuated

"Vaccines, Attenuated" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity.

Descriptor ID	D014613
MeSH Number(s)	D20.215.894.811
Concept/Terms	Vaccines, Attenuated Vaccines, Attenuated Attenuated Vaccines Vaccines, Live, Attenuated

Below are MeSH descriptors whose meaning is more general than "Vaccines, Attenuated".

Chemicals and Drugs [D]
Complex Mixtures [D20]
Biological Products [D20.215]
Vaccines [D20.215.894]
Vaccines, Attenuated [D20.215.894.811]

Below are MeSH descriptors whose meaning is related to "Vaccines, Attenuated".

Below are MeSH descriptors whose meaning is more specific than "Vaccines, Attenuated".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vaccines, Attenuated" by people in this website by year, and whether "Vaccines, Attenuated" was a major or minor topic of these publications.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
1998	1	0	1
2002	0	1	1
2005	0	1	1
2008	1	1	2
2011	0	1	1
2014	0	1	1
2015	0	1	1

Below are the most recent publications written about "Vaccines, Attenuated" by people in Profiles.

Peebles ED, Jacob R, Branton SL, Evans JD, Leigh SA, Gerard PD. Effects of different vaccine combinations against Mycoplasma gallisepticum on the digestive and reproductive organ characteristics of commercial egg-laying hens. Poult Sci. 2015 Dec; 94(12):2898-904.

View in: PubMed
Peebles ED, Jacob R, Branton SL, Gerard PD. Effects of Mycoplasma gallisepticum vaccination on serum a1-acid glycoprotein concentrations in commercial layer chickens. Poult Sci. 2014 Jun; 93(6):1396-402.

View in: PubMed
Chandwani S, Beeler J, Li H, Audet S, Smith B, Moye J, Nalin D, Krasinski K. Safety and immunogenicity of early measles vaccination in children born to HIV-infected mothers in the United States: results of Pediatric AIDS Clinical Trials Group (PACTG) protocol 225. J Infect Dis. 2011 Jul; 204 Suppl 1:S179-89.

View in: PubMed
Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, Cortese M, Braun MM, Belongia EA, Miller E, Ball R, Iskander J, Parashar UD. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008 Jun; 121(6):1206-12.

View in: PubMed
Vance AM, Branton SL, Collier SD, Gerard PD, Peebles ED. Effects of time-specific F-strain Mycoplasma gallisepticum inoculation overlays on prelay ts11-strain Mycoplasma gallisepticum inoculation on performance characteristics of commercial laying hens. Poult Sci. 2008 Apr; 87(4):655-60.

View in: PubMed
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005 Jun 02; 352(22):2271-84.

View in: PubMed
Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, Sacci J, de la Vega P, Dowler M, Paul C, Gordon DM, Stoute JA, Church LW, Sedegah M, Heppner DG, Ballou WR, Richie TL. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002 Apr 15; 185(8):1155-64.

View in: PubMed
Ockenhouse CF, Sun PF, Lanar DE, Wellde BT, Hall BT, Kester K, Stoute JA, Magill A, Krzych U, Farley L, Wirtz RA, Sadoff JC, Kaslow DC, Kumar S, Church LW, Crutcher JM, Wizel B, Hoffman S, Lalvani A, Hill AV, Tine JA, Guito KP, de Taisne C, Anders R, Ballou WR, et al. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis. 1998 Jun; 177(6):1664-73.

View in: PubMed
Gruber WC, Darden PM, Still JG, Lohr J, Reed G, Wright PF. Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response. Vaccine. 1997 Aug-Sep; 15(12-13):1379-84.

View in: PubMed
Chumakov KM, Powers LB, Noonan KE, Roninson IB, Levenbook IS. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine. Proc Natl Acad Sci U S A. 1991 Jan 01; 88(1):199-203.

View in: PubMed

People

Explore

Similar Concepts

Top Journals